Galactokinase

半乳糖激酶是参与半乳糖代谢的关键酶,主要负责将半乳糖磷酸化为半乳糖-1-磷酸。半乳糖激酶功能障碍会导致代谢疾病,如常染色体隐性遗传病半乳糖血症,其中代谢异常的半乳糖及其代谢物在体内积聚,可能导致智力障碍、肝功能障碍和白内障[1]。

Galactokinase is a key enzyme involved in galactose metabolism, mainly responsible for phosphorylating galactose to galactose-1-phosphate. Galactokinasedysfunction leads to metabolic disorders such as the autosomal recessive genetic disease galactosemia, in which abnormal metabolized galactose and its metabolite accumulates in the body, causing probably intellectual disability, liver dysfunction and cataracts[1].

By Effects: Inhibitor (2)
共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
GALK1-IN-1

GALK1-IN-1(化合物4)是一种半乳糖激酶抑制剂,其IC50为4.2129 μM。

669718-48-3
Inhibitor
98.17%
GALK1-IN-1
NCGC00238624

NCGC00238624 是一种选择性半乳糖激酶 (GALK1) 抑制剂,对人和小鼠重组 GALK1 的 IC50 分别为 7.69 μM 和 13.67 μM,在 10 μM 浓度下对 GALK2 和其他激酶无活性,可用于经典半乳糖血症的研究。

2768230-55-1
Inhibitor
NCGC00238624

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础